A neurological examination can point toward other causes of cognitive change and help guide an Alzheimer's evaluation. Its central limitation is that it cannot diagnose Alzheimer's disease by itself. The examination checks functions such as reflexes, coordination, strength, eye movements, speech, and sensation. The Alzheimer's Association explains that clinicians interpret these findings alongside medical history, cognitive and functional testing, laboratory tests, and sometimes imaging or biomarkers.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What happens during the examination?
- What are the main benefits?
- Where does the examination fall short?
- How should you prepare?
- What may happen after the examination?
What happens during the examination?
The clinician may test balance, coordination, reflexes, muscle tone, strength, sensation, speech, and eye movements. These tasks show whether different parts of the nervous system appear to be working normally. The results can reveal patterns that deserve further investigation.
For example, problems with movement, sensation, or coordination may suggest that memory loss is not the only neurological issue. The examination is only one part of the appointment. Clinicians also need to understand when symptoms began, how they have changed, and whether they interfere with everyday activities.
What are the main benefits?
The most important benefit is finding clues to conditions other than Alzheimer's. The National Institute on Aging identifies possibilities including stroke, Parkinson's disease, brain tumors, hydrocephalus, medication effects, infections, sleep disturbances, and other dementias. Some alternative explanations may be treatable or reversible.
Identifying them can prevent someone from being incorrectly labeled with Alzheimer's and help direct the next tests or treatments. An accurate diagnosis also supports practical planning. The affected person and family can address safety, future care, legal and financial matters, support needs, and possible clinical-trial participation.
Where does the examination fall short?
A neurological examination cannot establish what is causing cognitive symptoms on its own. Similar concerns can arise from different medical, neurological, medication-related, or sleep-related problems. A normal result does not prove that Alzheimer's is absent.
An initial evaluation may also be inconclusive, especially when the available history does not clearly show how thinking and daily function have changed. The examination also does not confirm Alzheimer-related biology. That requires other evidence, and even biological test results must be interpreted in the context of symptoms and the wider clinical assessment.
How should you prepare?
The evaluation is most useful when a person has memory or thinking symptoms. Before the appointment, organize information that will help the clinician understand the pattern and practical impact of those changes.
Another person's account can be especially valuable when the patient does not recognize certain changes. The clinician may ask that person about daily function, behavior, and personality as part of the diagnostic process.
- Note which memory or thinking problems have appeared and whether they are worsening.
- Describe changes in everyday tasks, behavior, or personality.
- Bring an accurate medication list because medication effects can contribute to cognitive problems.
- Ask a trusted family member or friend to attend or provide observations.
What may happen after the examination?
The next steps may include cognitive and functional testing, blood or other laboratory tests, brain imaging, or Alzheimer's biomarker testing. Under the Alzheimer's Association's specialty-care guideline, biomarkers should be used for symptomatic people when knowing whether Alzheimer biology is present would benefit the patient; they do not replace clinical judgment.
An FDA-cleared blood test offers adults aged 55 or older with cognitive symptoms a less-invasive option than PET imaging or spinal-fluid testing. However, the FDA warns that it is neither a screening test nor a stand-alone diagnosis because false results could lead to inappropriate treatment or delayed care. If symptoms keep worsening after a normal or inconclusive evaluation, ask what additional testing is appropriate or seek a second opinion.
